10x Genomics CEO Sells Nearly 30,000 Shares. Here's What That Means for Investors.

Source · https://www.fool.com/coverage/filings/2026/06/01/10x-genomics-ceo-sells-nearly-30-000-shares-here-s-what-that-means-for-investors/

Search tags

Story key points

3 claims · impact-rated

What matters in this story

1
10x Genomics reduced its Q1 net loss to $13.5 million from $34.4 million in the prior year through effective cost management. — Significant improvement in the bottom line and cost discipline is a positive fundamental indicator for a growth-stage company.
+0.40
2
10x Genomics reported a 3% year-over-year decline in first-quarter revenue to $150.8 million. — A decline in top-line growth suggests slowing demand or pricing pressure in their core genomics markets.
-0.30
3
CEO Serge Saxonov sold 28,893 shares of common stock totaling approximately $709,000 in late May. — Insider selling can be perceived negatively, though the impact is muted here as the sales were for taxes and pre-planned 10b5-1 trades.
-0.10

Ticker attribution

Model heads

6 related stories

News Impact Screener — Catch market-moving news before the crowd